Birgit Wackwitz
Overview
Explore the profile of Birgit Wackwitz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
154
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fasching P, Jud S, Hauschild M, Kummel S, Schutte M, Warm M, et al.
BMC Cancer
. 2014 Feb;
14:66.
PMID: 24499441
Background: The objective of this prospectively randomized phase II trial (Trial registration: EUCTR2004-004007-37-DE) was to compare the clinical response of primary breast cancer patients to neoadjuvant therapy with letrozole alone...
2.
Banys M, Solomayer E, Gebauer G, Janni W, Krawczyk N, Lueck H, et al.
BMC Cancer
. 2013 Oct;
13:480.
PMID: 24128322
Background: The presence of disseminated tumor cells (DTC) in bone marrow (BM) of breast cancer patients is associated with reduced clinical outcome. Bisphosphonate treatment was shown to eradicate DTC from...
3.
Humair B, Wackwitz B, Haas D
Appl Environ Microbiol
. 2010 Jan;
76(5):1497-506.
PMID: 20048056
The Gac/Rsm signal transduction pathway positively regulates secondary metabolism, production of extracellular enzymes, and biocontrol properties of Pseudomonas fluorescens CHA0 via the expression of three noncoding small RNAs, termed RsmX,...
4.
Krainick-Strobel U, Lichtenegger W, Wallwiener D, Tulusan A, Janicke F, Bastert G, et al.
BMC Cancer
. 2008 Feb;
8:62.
PMID: 18302747
Background: In recent years, preoperative volume reduction of locally advanced breast cancers, resulting in higher rates of breast-conserving surgery (BCS), has become increasingly important also in postmenopausal women. Clinical interest...
5.
Treeck O, Wackwitz B, Haus U, Ortmann O
Gynecol Oncol
. 2006 Jan;
102(2):292-9.
PMID: 16443261
Objective: Interactions between estrogen receptor signaling and the PI3K/Akt pathway are present in estrogen-dependent cancer cells. Therapeutical inhibition of each of these pathways has been proven to exert antitumoral effects....